Clinical Trial Update: Pemetrexed and Cisplatin as Treatment in Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating pemetrexed plus cisplatin in small cell lung cancer; the study was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Pemetrexed (pemetrexed)
• Platinol (cisplatin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Small Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2009-05-25